Schoester M - Search Results

1

Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells.

te Boekhorst PA, de Leeuw K, Schoester M, Wittebol S, Nooter K, Hagemeijer A, Löwenberg B, Sonneveld P. te Boekhorst PA, et al. Among authors: schoester m. Blood. 1993 Nov 15;82(10):3157-62. Blood. 1993. PMID: 7693039 Free article.

2

Reversal of typical multidrug resistance by cyclosporin and its non-immunosuppressive analogue SDZ PSC 833 in Chinese hamster ovary cells expressing the mdr1 phenotype.

te Boekhorst PA, van Kapel J, Schoester M, Sonneveld P. te Boekhorst PA, et al. Among authors: schoester m. Cancer Chemother Pharmacol. 1992;30(3):238-42. doi: 10.1007/BF00686322. Cancer Chemother Pharmacol. 1992. PMID: 1352739 Free article.

3

Clinical modulation of multidrug resistance in multiple myeloma: effect of cyclosporine on resistant tumor cells.

Sonneveld P, Schoester M, de Leeuw K. Sonneveld P, et al. Among authors: schoester m. J Clin Oncol. 1994 Aug;12(8):1584-91. doi: 10.1200/JCO.1994.12.8.1584. J Clin Oncol. 1994. PMID: 7518859

4

Analysis of multidrug-resistance (MDR-1) glycoprotein and CD56 expression to separate monoclonal gammopathy from multiple myeloma.

Sonneveld P, Durie BG, Lokhorst HM, Frutiger Y, Schoester M, Vela EE. Sonneveld P, et al. Among authors: schoester m. Br J Haematol. 1993 Jan;83(1):63-7. doi: 10.1111/j.1365-2141.1993.tb04632.x. Br J Haematol. 1993. PMID: 7679588

5

High expression of the multidrug resistance P-glycoprotein in high-risk myelodysplasia is associated with immature phenotype.

Sonneveld P, van Dongen JJ, Hagemeijer A, van Lom K, Nooter K, Schoester M, Adriaansen HJ, Tsuruo T, de Leeuw K. Sonneveld P, et al. Among authors: schoester m. Leukemia. 1993 Jul;7(7):963-9. Leukemia. 1993. PMID: 8100604

6

Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activity.

Broxterman HJ, Sonneveld P, Feller N, Ossenkoppele GJ, Währer DC, Eekman CA, Schoester M, Lankelma J, Pinedo HM, Löwenberg B, Schuurhuis GJ. Broxterman HJ, et al. Among authors: schoester m. Blood. 1996 Jun 1;87(11):4809-16. Blood. 1996. PMID: 8639853 Free article.

7

In vitro effect of GF120918, a novel reversal agent of multidrug resistance, on acute leukemia and multiple myeloma cells.

den Ouden D, van den Heuvel M, Schoester M, van Rens G, Sonneveld P. den Ouden D, et al. Among authors: schoester m. Leukemia. 1996 Dec;10(12):1930-6. Leukemia. 1996. PMID: 8946933

8

MDR 1 expression is an independent prognostic factor for response and survival in de novo acute myeloid leukaemia.

van den Heuvel-Eibrink MM, van der Holt B, te Boekhorst PA, Pieters R, Schoester M, Löwenberg B, Sonneveld P. van den Heuvel-Eibrink MM, et al. Among authors: schoester m. Br J Haematol. 1997 Oct;99(1):76-83. doi: 10.1046/j.1365-2141.1997.3343148.x. Br J Haematol. 1997. PMID: 9359506 Free article.

9

In vitro Ig-synthesis and proliferative activity in multiple myeloma are stimulated by different growth factors.

Sonneveld P, Schoester M, de Leeuw K. Sonneveld P, et al. Among authors: schoester m. Br J Haematol. 1991 Dec;79(4):589-94. doi: 10.1111/j.1365-2141.1991.tb08086.x. Br J Haematol. 1991. PMID: 1772780

10

MDR-1 expression and response to vincristine, doxorubicin, and dexamethasone chemotherapy in multiple myeloma refractory to alkylating agents.

Cornelissen JJ, Sonneveld P, Schoester M, Raaijmakers HG, Nieuwenhuis HK, Dekker AW, Lokhorst HM. Cornelissen JJ, et al. Among authors: schoester m. J Clin Oncol. 1994 Jan;12(1):115-9. doi: 10.1200/JCO.1994.12.1.115. J Clin Oncol. 1994. PMID: 7903690

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters